ICON

ICLR | NASDAQ | 4 Followers
$145.45 +0.62% $0.89
Follow
Overview Metrics Financials
Loading...

Fair Price

$282.48
Undervalued by 24.5%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

ICON Public Limited Company (ICLR) is a global company providing solutions in the field of drug research and development and biotechnology. The company offers comprehensive services including clinical research, consulting, and strategic planning for pharmaceutical, biotechnology, and medical companies. Their portfolio includes a wide range of services from study design to commercial drug development and support for post-market activities. ICON focuses on providing high quality and efficiency in all stages of drug development to help customers accelerate the drug development process and improve the success of their products. The company also actively invests in innovations and technological advancements to provide the latest and best solutions for its clients. ICON Public Limited Company (ICLR) shares may be attractive to investors seeking investments in companies operating in the field of drug research and development and biotechnology with a global reach and a strong background in research and innovation.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade